Medical science：Cancer challenge
癌症治疗的新方案

Can remarkable science be turned into mass-market products, asks David Crow. Cell therapies to treat blood cancers offer hope to patients who have exhausted all other possibilities and are likely to get regulatory approval this year. But they are expensive and production is time consuming, says David. The process needs to be streamlined and capacity matched to demand.
令人瞩目的科学突破最终能转化为满足大众市场需求的医疗产品吗？治疗血液癌症的细胞疗法为四处碰壁的患者提供了新的希望，并有望在今年内获得监管批准。但它不仅成本高昂，生产也非常耗时……